News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Datatrial Announces Dr. Emma Banks as New Chief Executive Officer


9/7/2011 11:31:52 AM

Newcastle upon Tyne, 7 September, 2011—Datatrial, a boutique clinical data management organization, has announced a change in chief executive duties, with chief operating officer Dr. Emma Banks taking over the CEO role effective 1st October. Adam Black will move from CEO to non-executive director of the company, ensuring he’ll play an active role in supporting Datatrial’s continued growth as a trusted contract research organisation.

In more than a decade with the company, Black played an integral role in helping Datatrial progress from a startup into a respectable, profitable business. With the organisation on firm footing and demonstrating consistent success, he elected to concentrate on his role on the board of directors.

“The time is right for Datatrial to move into the future with an industry specialist leading the way,” Black said. “The board views this as part of the natural progression of the company, and we have the utmost confidence that, thanks to her profile on the biopharma landscape, Emma is the ideal person to lead Datatrial to even greater heights.”

Dr. Banks has been a regular speaker at key industry trade shows in recent years, and her eight years at Datatrial have given her a keen feel for the values and goals of the company. With an extensive background in research, data management, business development and operations, she is uniquely qualified to lend industry insights to the role of CEO.

“This transition represents an exciting opportunity for both myself and Datatrial,” said Dr. Banks. “I am eager to continue with our focus on customer service, corporate culture, and engaging with existing and new customers, and I am also thankful that Adam will remain involved in our pursuit of study delivery excellence.”

With Black maintaining a presence on the board of directors, the composition of the board will remain intact. Chief financial officer David Walton and non-executive chairman David Stonehouse, who will both be essential in supporting these changes, remain as members of the board along with Dr. Banks and Black. Over the next few weeks, the board will collaborate exensively to ensure a smooth succession plan both internally and externally.

About Datatrial

Datatrial is a boutique clinical data organization that provides the reliability of a big company, but the personalised service and flexibility of a more nimble provider. With more than 10 years of experience, we can design and deliver your study with insight and expertise, whether you want it conducted in paper or through our own innovative eClinical technologies. We offer thorough data management and bio-statistical services, as well as a suite of consulting and training options. Through our exceptional service delivery and a deep understanding of data best practices, we make clinical studies less of a trial.

For more information about Datatrial, please visit www.datatrial.com. You can also follow us on Twitter (@Datatrial) and subscribe to our DataBridge blog to stay updated on the most important industry issues.

If you'd like more information about this topic or would like to schedule an interview, please call Scott Vogelsberg at 919-573-4812, or e-mail him at scott.vogelsberg@datatrial.com.


Read at BioSpace.com


comments powered by Disqus
Datatrial
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES